SCHEMBL21277705

SCHEMBL21277705

CSc1ccc(CNC(=O)c2cnc3c(c2)CN(Cc2ccc(C#N)cc2)C3)cc1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RORC P51449 6/20 0.51
PRKAA2 P54646 4/20 0.51
CXCR3 P49682 2/20 0.47
EPHX2 P34913 2/20 0.43
KDM1A O60341 1/20 0.43
HDAC1 Q13547 1/20 0.43
ROCK2 O75116 1/20 0.43
NR1H4 Q96RI1 1/20 0.41
CHRM3 P20309 1/20 0.41
TP53 P04637 1/20 0.41
EGLN2 Q96KS0 1/20 0.41
MLLT3 P42568 1/20 0.41
MLLT1 Q03111 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20903811 0.91 RORC (0.50) RORCPRKAA2CXCR3EPHX2KDM1A
SCHEMBL20903789 0.89 CXCR3 (0.45) RORCCXCR3EPHX2NR1H4MLLT3
SCHEMBL20903757 0.88 MEN1 (0.50) RORCPRKAA2CXCR3EPHX2NR1H4
SCHEMBL21277885 0.86 RORC (0.65) RORCPRKAA2CXCR3EPHX2
SCHEMBL21277845 0.85 RORC (0.54) RORCEPHX2KDM1AHDAC1NR1H4
SCHEMBL20903773 0.85 RORC (0.52) RORCPRKAA2CXCR3TP53
SCHEMBL21277703 0.83 RORC (0.52) RORCCXCR3EPHX2NR1H4MLLT3
SCHEMBL21277711 0.80 CXCR3 (0.44) RORCCXCR3
SCHEMBL20903795 0.79 RORC (0.80) RORC
SCHEMBL21277787 0.79 RORC (0.53) RORCKDM1AHDAC1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3527569-A1 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA FOR USE IN TREATING DRYE EYE Vitae Pharmaceuticals, LLC (US) 2019-08-21 EP disclosed